NCT02065713 Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients Status COMPLETED Phase PHASE3
NCT01988961 A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT01900574 A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT01863771 A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis. Status COMPLETED Phase PHASE3
NCT01804166 A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) Status COMPLETED Phase PHASE4
NCT01718951 Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial Status COMPLETED Phase PHASE4
NCT01668004 The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) Status COMPLETED Phase PHASE4
NCT01526174 Intratympanic Injection for Autoimmune Inner Ear Disease Status TERMINATED Phase PHASE1/PHASE2
NCT01453725 Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) Status COMPLETED Phase PHASE3
NCT01426815 Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria Status COMPLETED Phase PHASE3
NCT01362153 A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1
NCT01295151 SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. Status COMPLETED Phase PHASE4
NCT01288157 A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects Status COMPLETED Phase PHASE1
NCT01248793 Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT01248780 Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy Status COMPLETED Phase PHASE3
NCT01217814 Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers Status TERMINATED Phase PHASE2
NCT01081717 Golimumab Safety and Surveillance Program Using the Ingenix NHI Database Status COMPLETED Phase N/A
NCT00973479 An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy Status COMPLETED Phase PHASE3
NCT00955279 A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis Status COMPLETED Phase PHASE2